Delivery Order SPE2DB22D1017-SPE2DB25FYRLM
Award Date 9/19/25
Potential Completion Date 9/22/25
Potential Value $12K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,452.88 to AmerisourceBergen Drug Corp for MENQUADFI vial 0.5mL on July 23, 2025, with an ultimate completion date of July 24, 2025. This firm fixed price delivery order, which is not set-aside, will be performed in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger prime indefinite delivery contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $10,896.60 for MENQUADFI vial 0.5ML pharmaceutical products on June 2, 2025, with an ultimate completion date of June 3, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed in Conshohocken, Pennsylvania, where the contractor maintains its corporate headquarters. The award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $2,905.80 to AmerisourceBergen Drug Corp for MENQUADFI vial 0.5ML on September 11, 2025, with completion targeted for September 12, 2025. This is a firm fixed-price contract with no set-aside designation, competitively awarded to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,579.74 to AmerisourceBergen Drug Corp for the supply of Menquadfi vial (0.5mL) under a firm fixed price, non-set-aside contract. The award was issued on July 21, 2025, with an ultimate completion date of July 22, 2025. AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania will serve as the place of performance. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $2,905.76 to AmerisourceBergen Drug Corp for MENQUADFI vials (0.5ML) on September 8, 2025, with an ultimate completion date of September 9, 2025. This competitively awarded, firm fixed-price contract is being performed in Conshohocken, Pennsylvania, where the vendor maintains its corporate headquarters. The delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's larger indefinite...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 11, 2025, by the Defense Logistics Agency for the supply of Menquadfi vial 0.5ML pharmaceutical product. This competitively awarded, non-set-aside contract has a ceiling value of $2,905.80 with firm fixed pricing and an ultimate completion date of August 12, 2025. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- This delivery order, valued at $14,528.80 and awarded September 3, 2025, represents a competitive procurement by the Defense Logistics Agency (DLA) for MENQUADFI vials (0.5mL) from AmerisourceBergen Drug Corp, the primary pharmaceutical distributor for federal military and healthcare systems. The award is non-set-aside and utilizes firm fixed-price pricing, with completion scheduled for September 4, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of...
- The Defense Logistics Agency awarded a delivery order valued at $1,452.90 to AmerisourceBergen Drug Corp for MENQUADFI VIAL 0.5ML on August 20, 2025, with an ultimate completion date of August 21, 2025. This competitively awarded, firm fixed-price contract was issued with no set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,179.32 to AmerisourceBergen Drug Corp for MENQUADFI VIAL 0.5ML, a pharmaceutical product. This firm fixed price contract, awarded on September 2, 2025, with a completion date of September 3, 2025, represents a child order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was not designated as a set-aside contract and will be performed at the contractor's location in...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $1,452.88 by the Defense Logistics Agency (DLA) for MENQUADFI VIAL 0.5ML, a pharmaceutical product. The contract is competitively awarded with no set-aside designation and operates under a firm fixed price structure, with an ultimate completion date of August 4, 2025. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a...